Author/Authors :
Sun، نويسنده , , Yanbin and Yu، نويسنده , , Bo and Wang، نويسنده , , Guoying and Wu، نويسنده , , Yongsheng and Zhang، نويسنده , , Xiaomin and Chen، نويسنده , , Yanmin and Tang، نويسنده , , Suoqing and Yuan، نويسنده , , Yuan and Lee، نويسنده , , Robert J. and Teng، نويسنده , , Lesheng and Xu، نويسنده , , Shun، نويسنده ,
Abstract :
Nanoparticles are efficient delivery vehicles for cancer therapy such as paclitaxel (PTX). In this study, we formulated PTX into PLGA polymeric nanoparticles. Vitamin E TPGS was used as an emulsifier to stabilize the nanoparticle formulation. PTX was encapsulated in TPGS-emulsified polymeric nanoparticles (TENPs) by a nanoprecipitation method in ethanol–water system. The resultant PTX-TENPs showed a very uniform particle size (∼100 nm) and high drug encapsulation (>80%). The cytotoxicity of PTX-TENPs was examined in A549 lung cancer cell line. Preferential tumor accumulation of TENPs was observed in the A549 lung cancer xenograft model. Tumor growth was significantly inhibited by intravenous injection of PTX-TENPs. Our results suggested that the modified nanoprecipitation method holds great potential for the fabrication of the PTX loaded polymeric nanoparticles. TPGS can be used in the manufacture of polymeric nanoparticles for the controlled release of PTX and other anti-cancer drugs.
Keywords :
Paclitaxel , lung cancer , DRUG DELIVERY , Nanoparticles , chemotherapy , TPGS